Aclaris Therapeutics, Inc. Entity Public Float
Financial Statements › Balance Sheet › Equity
dei:EntityPublicFloat · last filed 2026-02-26
- 2025-06-30: Entity Public Float $149.20M.
- 2024-06-28: Entity Public Float $76.10M.
- 2023-06-30: Entity Public Float $712.60M.
- 2022-06-30: Entity Public Float $898.40M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $149.20M 10-K · filed 2026-02-26 |
| 2024-06-28 | $76.10M 10-K · filed 2025-02-27 |
| 2023-06-30 | $712.60M 10-K · filed 2024-02-27 |
| 2022-06-30 | $898.40M 10-K · filed 2023-02-23 |
| 2021-06-30 | $914.50M 10-K · filed 2022-02-24 |
| 2020-06-30 | $65.50M 10-K · filed 2021-02-25 |
| 2019-06-28 | $79.60M 10-K · filed 2020-02-25 |
| 2018-06-30 | $528.20M 10-K · filed 2019-03-18 |
| 2017-06-30 | $639.20M 10-K · filed 2018-03-12 |
| 2016-06-30 | $156.50M 10-K · filed 2017-03-15 |
| 2015-06-30 | $0.00 10-K · filed 2016-03-23 |